Invitae is a medical genetics company that bring comprehensive genetic information into mainstream medicine to improve healthcare.
Invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people.Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today.What’s our plan? It takes three steps:--Make genetic testing more affordable and accessible than ever before.--Build a secure and trusted genome management infrastructure.--Design a new global community for sharing genetic information to advance science and medicine.Today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. Together we can improve healthcare for billions of people.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 5, 2021 | Post-IPO Debt | $1.15B | 1 | SoftBank | — | Detail |
Jan 20, 2021 | Post-IPO Equity | $460M | — | — | — | Detail |
Apr 1, 2020 | Post-IPO Equity | $184M | — | — | — | Detail |
Feb 12, 2015 | IPO | $102M | — | — | — | Detail |
Oct 13, 2014 | Series F | $120M | 14 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
SoftBank | Yes | Post-IPO Debt |
Casdin Capital | — | Series F |
Decheng Capital | — | Series F |
Deerfield Capital Management | — | Series F |
Genesys Capital | — | Series F |
Genomic Health | — | Series F |
J.P. Morgan Securities Inc. | — | Series F |
OrbiMed | — | Series F |
Perceptive Advisors | — | Series F |
Redmile Group | — | Series F |
Invitae has acquired 14 organizations. Their most recent acquisition was AltaVoice on Jan 6, 2017. They acquired AltaVoice for 0.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Jan 6, 2017
AltaVoice
|
Biotechnology | acquisition | — | Detail |
Jun 12, 2017
CancerGene Connect
|
Genetics | acquisition | — | Detail |
Jul 31, 2017
CombiMatrix
|
Biotechnology | acquisition | $ 33M | Detail |
Jul 31, 2017
Good Start Genetics
|
Biotechnology | acquisition | $ 24.30M | Detail |
Jan 17, 2019
Singular Bio
|
Biotechnology | acquisition | — | Detail |